RecallDepth
Class II Terminated

Estradiol Transdermal System Delivers 0.0375 mg/day, 8 Systems/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-3437-8

This recall has been terminated (originally issued April 28, 2021).

Company
Noven Pharmaceuticals, Inc.
Recall Initiated
April 16, 2021
Posted
April 28, 2021
Recall Number
D-0337-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
10872 cartons
Firm Location
Miami, FL, United States
Official Source
View on FDA website ↗

Reason for Recall

Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: 88321 Exp. 02/2022

More recalls by Noven Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls